This webpage is intended for UK healthcare professionals. If you are not a healthcare professional, please click here.
Offering the simplicity of a button-free autoinjector, purpose designed with patient-friendly features – Available from March 2024
Key Account Managers
For information about the new Metoject® PEN, support or training materials please contact your Key Account Manager.
Kavin Coyle
Scotland & Northern Ireland
Metoject® PEN (methotrexate)
Julie Steele
North West England & North Wales
Metoject® PEN (methotrexate)
Rob Hirst
North East England & Yorkshire
Metoject® PEN (methotrexate)
Laura Delcre
South West England & South Wales
Metoject® PEN (methotrexate)
Sally Terry
The Midlands
Metoject® PEN (methotrexate)
Dhanveer Bansal
East Anglia, North Central and North East London
Metoject® PEN (methotrexate)
Pavraj Powar
South East London, South West London and South East England
Metoject® PEN (methotrexate)
Karen Anthony
North West London, South Central and Thames Valley
Metoject® PEN (methotrexate)Medicines Information
For medicines information enquiries about Metoject® PEN, please contact the Medicines Information Department at medac Pharma using the information or the form below.
Our normal enquiry service is available from 9am to 5pm Monday to Friday. However, we do offer an emergency service outside these hours for urgent enquiries.
Contact Form
Metoject® PEN
Reporting Side Effects
Adverse events should be reported using the forms and information found at yellowcard.mhra.gov.uk
Please also report any adverse events by email to medac drug safety at drugsafety@medac.de